VITAL KSK HLDGS INC. Logo
JP3778280002
A0RL7T
3151.T

VITAL KSK HLDGS INC.

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, VITAL KSK HLDGS INC. has already paid €0.19 in dividends. The last payout was in June.

Financials

In the last quarter, VITAL KSK HLDGS INC. had revenue of €869.67M and net profit of €582.74K
(EUR) September 2026
YoY
Revenue 869.67M 0.66%
Gross profit 66.86M 3.85%
Net profit 582.74K 97.63%
EBITDA 5.96M 85.61%

Fundamentals

Metric Value
Market capitalization
€371.21M
Number of shares
47.5M
52-week high/low
€9.75 - €7.02
Dividend yield
4.94%
Dividends TTM
€0.38
Next dividend
€0.20
Beta
0.27
P/E ratio
23.42
PEG ratio
-0.33
P/B ratio
0.56
P/S ratio
0.11

Company profile

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.

Name
VITAL KSK HLDGS INC.
CEO
Taisuke Murai
Headquarters Tokyo, ty
Japan
Website
IPO
01/01/2001
Employees 3,871

Ticker symbols

Exchange Symbol
Japan Exchange Group
3151.T
🍪

Parqet  uses cookies. Learn more